Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1647-1649, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1647-1649.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Evaluation of Candida ID, a New Chromogenic Medium
for Fungal Isolation and Preliminary Identification of Some
Yeast Species
H.
Fricker-Hidalgo,1,*
S.
Orenga,2
B.
Lebeau,1
H.
Pelloux,1
M. P.
Brenier-Pinchart,1
P.
Ambroise-Thomas,1 and
R.
Grillot1
Service de Parasitologie-Mycologie, Centre
Hospitalier Universitaire, 38043 Grenoble,1 and
bioMérieux, Le Zaligniez, 38390 La
Balme-les-Grottes,2 France
Received 3 October 2000/Returned for modification 14 November
2000/Accepted 19 January 2001
 |
ABSTRACT |
Candida ID, a new chromogenic medium, allows identification of
Candida albicans (blue colonies) and preliminary
identification into a group of four species (pink colonies). In
comparison with Albicans ID2 and Sabouraud gentamicin chloramphenicol
on 446 fungal strains, Candida ID allowed the isolation of more species
than Albicans ID 2 (95.5% versus 91.2%).
 |
TEXT |
Mycoses are a growing medical
problem requiring prompt diagnosis with species identification and
early adapted antifungal therapy (3, 7, 11, 14). The
importance of identifying the pathogen quickly (20), as
well as the difficulty in detecting mixed cultures in the same plate
with the traditional Sabouraud glucose agar medium (2),
has fostered the development of differential media for the
identification of yeasts (1, 5, 6, 8, 12, 18, 19, 22).
Candida ID (CAID) (bioMérieux, Marcy l'Etoile, France) is a
recently commercialized, ready-to-use medium. CAID was developed to
improve the isolation of yeasts, the identification of Candida
albicans and C. dubliniensis, the detection of mixed cultures, and the preliminary identification of other species (C. tropicalis, C. guilliermondii, C. kefyr, and C. lusitaniae, which produce pink colonies). Further testing has to
be performed to separate these four species. In our study, CAID was
compared with Albicans ID2 (AID2) (bioMérieux) and Sabouraud
gentamicin chloramphenicol agar (SGC) using 307 collection strains and
139 strains from 220 clinical samples.
A total of 307 fungal strains (247 yeasts and 60 filamentous fungi)
from bioMérieux and Grenoble hospital collections were tested on
the three media. The collection strains were subcultured on Sabouraud
agar plates and incubated for 2 to 5 days at 35 or 27°C according to
the species. For all isolates, a suspension of the organisms was made
in physiological saline and seeded onto three plates (CAID, AID2, and
SGC). The plates were incubated at 35°C except for
Penicillium and Fusarium spp., which were
incubated at 27°C. Equivalent amounts of each of the 220 clinical
samples were directly applied to the three media and incubated at
35°C. The reading of the plates and interpretation of the results
were carried out after 24, 48, and 72 h of incubation. The
determination of the color, the number, and the diameter of the
different colonies grown on CAID, AID2, and SGC was performed at each
reading step. The colonies showing different morphologies on media
inoculated with clinical samples were picked up and identified by
conventional mycological methods (15): Bichrolatex
albicans, Krusei color (Fumouze, Levallois-Perret, France)
(13), ID32C (bioMérieux), and macroscopic and
microscopic observations. The colony detections on CAID, AID2, and SGC
were compared and analyzed in terms of sensitivity (number of true
positives/number of true positives plus the number of false negatives)
and specificity (number of true negatives/number of true negatives plus
the number of false positives). The data were statistically analyzed by
2 test. C. albicans identification on CAID
and AID2 was analyzed in terms of sensitivity and specificity using the
described conventional mycological methods as a reference.
CAID supported the growth of more strains (426 of 446, 95.5%) than
AID2 (407 of 446, 91.2%) and as many as SGC (426 of 446, 95.5%)
(Tables 1 and
2). The differences between CAID and AID2 were statistically significant (P < 0.025). Among the
220 clinical specimens, 103 gave positive cultures (43 stools, 14 tracheal fluids, 14 bronchoscopic aspirations, 30 sputum specimens, and 2 miscellaneous samples such as drain fluid) (Table 2). For the 31 polyfungal specimens, AID2 and CAID supported the growth of more fungus
strains (62 of 67, 92.5%) than SGC (53 of 67, 79.1%), with
statistically significant differences (P < 0.05). The
sensitivities of CAID and AID2 for detection and differentiation of
C. albicans were 97.6% (125 of 128) and 100% (128 of 128),
respectively, and the specificities were 89.7 and 82.7%, respectively.
The colonies of 17 among 36 isolates of C. tropicalis were
blue on AID2 but not on CAID. CAID and AID2 did not enable
differentiation between C. albicans and C. dubliniensis. On CAID, colonies of C. tropicalis (32 of
36), C. lusitaniae (10 of 10), C. guilliermondii
(9 of 10), and C. kefyr (14 of 14) were pink after 72 h
of incubation and needed complete identification. The time to detection
of fungi growing on all three media (388 strains) were determined.
After 24 h of incubation at 35°C, 90.7% (352 of 388) of the
fungus strains were detected on SGC, 86.3% (335 of 388) were detected
on AID2, and 89.7% (348 of 388) were detected on CAID. The average
sizes of the colonies of collection strains after 24 h of
incubation on SGC, AID2, and CAID were 0.63 ± 0.46, 0.86 ± 0.56, and 0.94 ± 0.55 mm, respectively. Bacteria were isolated
from 23 of the 220 clinical samples (10.5%) on at least one of the
three media. The numbers of bacterial strains isolated on SGC, AID2,
and CAID were 14, 14, and 20, respectively.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Colonial coloration observed after 72 h of
incubation on the three media. (SGC, AID2, and CAID) inoculated with
307 collection strains
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Colonial coloration observed after 72 h of
incubation on the three media (SGC, AID2, and CAID) inoculated with 103 clinical samples
|
|
CAID was developed to obtain better results than with AID2 (4, 9,
10, 17, 21). Our study showed that CAID allowed a better
detection of different types of collection strains than AID2 (95.4 and
89.2%, respectively) and that the results from clinical samples were
equivalent with CAID and AID2 (95.7%). The collection strains detected
only on CAID belonged to species that were not isolated from the
clinical samples in our study (C. colliculosa, C. famata, C. intermedia, C. sphaerica, C. utilis, C. zeylanoides, Cryptococcus
humicolus, Cryptococcus laurentii, and Rhodotorula rubra). The other advantage of CAID related to the specificity of
C. albicans identification. No C. tropicalis
colonies were blue on CAID in contrast to what happens on AID2.
C. lodderae and C. rugosa, which produce blue
colonies on CAID, were rarely isolated from clinical specimens
(16), blue Trichosporon colonies were easily
differentiated from C. albicans by their macroscopic morphology, while C. dublinensis was not distinguished from
C. albicans. Furthermore, when different yeast species were
mixed in a single sample and plated out on CAID, the distinction
between colony colors and forms was extremely easy to do.
Discrimination of C. kefyr, C. lusitaniae, C. tropicalis,
and C. guilliermondii from other yeasts by their pink
colonies facilitates their definitive identification particularly for
C. guilliermondii which has the same profile as C. famata on the ID32C strip. On CAID, the colonies of C. guilliermondii were pink while the colonies of C. famata were white; thus, no other complementary test (different
from ID32C) was necessary.
In conclusion, our study shows that CAID is an effective, ready-to-use
medium for the isolation of fungi and identification of C. albicans from samples in clinical laboratories.
 |
ACKNOWLEDGMENTS |
We thank L. Barbaux, C. Cotte, A. Rongier, L. Coeur, C. Pinel, and
A. De Bengy for their technical assistance and S. Bastin for rereading
the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Service de
Parasitologie-Mycologie, Centre Hospitalier Universitaire, B.P. 217, 38043 Grenoble, France. Phone: 33-4-76-76-54-90. Fax: 33-4-76-76-56-60. E-mail: HFricker-Hidalgo{at}chu-grenoble.fr.
 |
REFERENCES |
| 1.
|
Ainscough, S., and C. C. Kibbler.
1998.
An evaluation of the cost-effectiveness of using Chromagar for yeast identification in a routine microbiology laboratory.
J. Med. Microbiol.
47:623-628[Abstract].
|
| 2.
|
Al Hedaithy, S. S. A., and R. Fotedar.
1998.
Recovery of multiple species of yeasts from single clinical specimen culture.
J. Mycol. Med.
8:153-155.
|
| 3.
|
Anaissie, E. J.
1992.
Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.
Clin. Infect. Dis.
14(Suppl. 1):S43-S51.
|
| 4.
|
Baumgartner, C.,
A. M. Freydière, and Y. Gille.
1996.
Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates.
J. Clin. Microbiol.
34:454-456[Abstract].
|
| 5.
|
Beighton, D.,
R. Ludford,
D. T. Clark,
S. R. Brailsford,
C. L. Pankhurst,
G. F. Tinsley,
J. Fiske,
D. Lewis,
B. Daly,
N. Khalifa,
V. Marren, and E. Lynch.
1995.
Use of CHROMagar Candida medium for isolation of yeasts from dental samples.
J. Clin. Microbiol.
33:3025-3027[Abstract].
|
| 6.
|
Bouchara, J. P.,
P. Declerck,
B. Cimon,
C. Planchenault,
L. de Gentile, and D. Chabasse.
1996.
Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations.
Clin. Microbiol. Infect.
2:202-208[Medline].
|
| 7.
|
Buchaille, L.,
A. M. Freydière,
R. Guinet, and Y. Gille.
1998.
Evaluation of six commercial systems for identification of medically important yeasts.
Eur. J. Clin. Microbiol. Infect. Dis.
17:479-488[Medline].
|
| 8.
|
Campbell, C. K.,
A. D. Holmes,
K. G. Davey,
A. Szekely, and D. W. Warnock.
1998.
Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans.
Eur. J. Clin. Microbiol. Infect. Dis.
17:367-368[Medline].
|
| 9.
|
Contreras, I.,
R. San-Millan,
A. Agustin-Barrasa,
J. Ponton, and G. Quindos.
1996.
Utility of Albicans ID plate for rapid identification of Candida albicans in clinical samples.
Mycopathologia
136:17-20[CrossRef][Medline].
|
| 10.
|
De Champs, C.,
B. Lebeau,
P. Ambroise-Thomas, and R. Grillot.
1995.
Evaluation of Albicans ID plates.
J. Clin. Microbiol.
33:2227-2228[Medline].
|
| 11.
|
Edwards, J. E., et al.
1997.
International conference for the development of a consensus on the management and prevention of severe candidal infections. 1997.
Clin. Infect. Dis.
25:43-59[Medline].
|
| 12.
|
Freydière, A. M.,
L. Buchaille, and Y. Gille.
1997.
Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens.
Eur. J. Clin. Microbiol. Infect. Dis.
16:464-467[CrossRef][Medline].
|
| 13.
|
Freydière, A. M.,
L. Buchaille,
R. Guinet, and Y. Gille.
1997.
Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies.
J. Clin. Microbiol.
35:877-880[Abstract].
|
| 14.
|
Freydière, A. M., and R. Guinet.
1997.
Rapid methods for identification of the most frequent clinical yeasts.
Rev. Iberoam Micol.
14:82-87.
|
| 15.
|
Grillot, R.
1996.
Les mycoses humaines: démarche diagnostique.
Elsevier, Paris, France.
|
| 16.
|
Hazen, K. C.
1995.
New and emerging yeast pathogens.
Clin. Microbiol. Rev.
8:462-478[Abstract].
|
| 17.
|
Lipperheide, V.,
L. Andraka,
J. Ponton, and G. Quindos.
1993.
Evaluation of the Albicans ID® plate method for the rapid identification of Candida albicans.
Mycoses
36:417-420[Medline].
|
| 18.
|
Odds, F. C., and R. Bernaerts.
1994.
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
J. Clin. Microbiol.
32:1923-1929[Abstract/Free Full Text].
|
| 19.
|
Pfaller, M. A.,
A. Houston, and S. Coffmann.
1996.
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida (Torulopsis) glabrata. 1996.
J. Clin. Microbiol.
34:58-61[Abstract].
|
| 20.
|
Rex, J. H.,
M. G. Rinaldi, and M. A. Pfaller.
1995.
Resistance of Candida species to fluconazole.
Antimicrob. Agents Chemother.
39:1-8[Medline].
|
| 21.
|
Rousselle, P.,
A. M. Freydière,
P. J. Couillerot,
H. de Montclos, and Y. Gille.
1994.
Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates.
J. Clin. Microbiol.
32:3034-3036[Abstract/Free Full Text].
|
| 22.
|
San-Millan, R.,
L. Ribacoba,
J. Ponton, and G. Quindos.
1996.
Evaluation of a commercial medium for identification of Candida species.
Eur. J. Clin. Microbiol. Infect. Dis.
15:153-158[CrossRef][Medline].
|
Journal of Clinical Microbiology, April 2001, p. 1647-1649, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1647-1649.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ilkit, M., Hilmioglu, S., Tasbakan, M., Aydemir, S.
(2007). Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identification of vaginal yeast isolates. J Med Microbiol
56: 762-765
[Abstract]
[Full Text]
-
Sendid, B., Francois, N., Standaert, A., Dehecq, E., Zerimech, F., Camus, D., Poulain, D.
(2007). Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species. J Med Microbiol
56: 495-499
[Abstract]
[Full Text]
-
Eraso, E., Moragues, M. D., Villar-Vidal, M., Sahand, I. H., Gonzalez-Gomez, N., Ponton, J., Quindos, G.
(2006). Evaluation of the New Chromogenic Medium Candida ID 2 for Isolation and Identification of Candida albicans and Other Medically Important Candida Species.. J. Clin. Microbiol.
44: 3340-3345
[Abstract]
[Full Text]
-
Freydiere, A. M., Perry, J. D., Faure, O., Willinger, B., Tortorano, A. M., Nicholson, A., Peman, J., Verweij, P. E.
(2004). Routine Use of a Commercial Test, GLABRATA RTT, for Rapid Identification of Candida glabrata in Six Laboratories. J. Clin. Microbiol.
42: 4870-4872
[Abstract]
[Full Text]
-
Piens, M A, Perry, J D, Raberin, H, Parant, F, Freydiere, A M
(2003). Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories. J. Clin. Pathol.
56: 687-689
[Abstract]
[Full Text]
-
Himmelreich, U., Somorjai, R. L., Dolenko, B., Lee, O. C., Daniel, H.-M., Murray, R., Mountford, C. E., Sorrell, T. C.
(2003). Rapid Identification of Candida Species by Using Nuclear Magnetic Resonance Spectroscopy and a Statistical Classification Strategy. Appl. Environ. Microbiol.
69: 4566-4574
[Abstract]
[Full Text]
-
Freydiere, A.-M., Robert, R., Ploton, C., Marot-Leblond, A., Monerau, F., Vandenesch, F.
(2003). Rapid Identification of Candida glabrata with a New Commercial Test, GLABRATA RTT. J. Clin. Microbiol.
41: 3861-3863
[Abstract]
[Full Text]
-
Holland, J, Young, M L, Lee, O, C-A Chen, S
(2003). Vulvovaginal carriage of yeasts other than Candida albicans. Sex. Transm. Infect.
79: 249-250
[Abstract]
[Full Text]
-
Freydiere, A.-M., Parant, F., Noel-Baron, F., Crepy, M., Treny, A., Raberin, H., Davidson, A., Odds, F. C.
(2002). Identification of Candida glabrata by a 30-Second Trehalase Test. J. Clin. Microbiol.
40: 3602-3605
[Abstract]
[Full Text]
-
Letscher-Bru, V., Meyer, M.-H., Galoisy, A.-C., Waller, J., Candolfi, E.
(2002). Prospective Evaluation of the New Chromogenic Medium Candida ID, in Comparison with Candiselect, for Isolation of Molds and Isolation and Presumptive Identification of Yeast Species. J. Clin. Microbiol.
40: 1508-1510
[Abstract]
[Full Text]
-
OLVER, W.J., STAFFORD, J., CHEETHAM, P., BOSWELL, T.C.
(2002). Comparison of Candida ID medium with Sabouraud-chloramphenicol agar for the isolation of yeasts from clinical haematology surveillance specimens. J Med Microbiol
51: 221-224
[Abstract]
[Full Text]
-
Willinger, B., Hillowoth, C., Selitsch, B., Manafi, M.
(2001). Performance of Candida ID, a New Chromogenic Medium for Presumptive Identification of Candida Species, in Comparison to CHROMagar Candida. J. Clin. Microbiol.
39: 3793-3795
[Abstract]
[Full Text]